BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial | NeoGenomics Laboratories

Publication date

Mon, 05/25/2020 - 12:00

Category

Year

Subtitle

Published in Nature Medicine

External link

https://www.nature.com/articles/s41591-020-0880-x